Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
multiple sclerosis/мучнина
Веза се чува у привремену меморију
Страна 1 од 247 резултати
Nausea, vomiting and diarrhea: an unusual presentation of multiple sclerosis.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The case of a young woman who presented with nausea, vomiting and diarrhea is outlined; the etiology turned out to be a first attack of multiple sclerosis. Plausible mechanisms are discussed.
The cannabinoids: an overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The present paper describes the historical use of cannabis, starting with its use in Assyria and China. Recent advances in the understanding of the molecular basis of cannabis action are explained, including the identification of the cannabinoid receptors CB(1) and CB(2), as well as the isolation of
Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Visually induced paroxysmal nausea and vomiting as presenting manifestations of multiple sclerosis.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Both paracetamol and ibuprofen are equally effective in managing flu-like symptoms in relapsing-remitting multiple sclerosis patients during interferon beta-1a (AVONEX) therapy.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Interferon beta-1a is an established therapy for patients with relapsing-remitting multiple sclerosis (MS). Adverse effects in the first weeks of treatment are common. This open-label, multicenter, randomized, prospective study compared treatment of flu-like symptoms (FLS) with paracetamol versus
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Cyclophosphamide is an alkylating agent used to treat malignancies and immune-mediated inflammatory non-malignant processes such as lupus nephritis and immune-mediated neuropathies. It has been studied as a treatment for multiple sclerosis (MS) for the past 30 years and is used by physicians in
The safety profile of cyclophosphamide in multiple sclerosis therapy.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Cyclophosphamide (Cyc) is an alkylating agent used to treat malignancies and autoimmune diseases, such as lupus nephritis, rheumatoid arthritis and immune-mediated neuropathies. Over the past 40 years, Cyc has also been applied to treat multiple sclerosis (MS) and the effective stabilisation of
Mitoxantrone in relapsing-remitting and rapidly progressive multiple sclerosis: Ten-year clinical outcomes post-treatment with mitoxantrone
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Background: Mitoxantrone (MTX) has been used as an effective disease modifying treatment (DMT) in multiple sclerosis (MS). Evidence from studies demonstrates benefits of reduced relapse rates, MRI disease activity and disability
Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
One hundred sixty-four patients with chronic progressive multiple sclerosis (MS) have been treated with a regimen of high-dose IV cyclophosphamide and ACTH over the past 6 years. Their status was reviewed to determine complications associated with treatment, dosage of medication used to induce a
Cryptococcal meningitis in a patient with multiple sclerosis on dimethyl fumarate treatment: A case report.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
INTRODUCTION
We present a case of meningitis caused by Cryptococcus neoformans var. grubii in a 46-year old non-HIV-infected patient with multiple sclerosis, treated with dimethyl fumarate monotherapy. We identified no other risk factors for developing cryptococcal meningitis.Multiple sclerosis as a cause of the acute vestibular syndrome.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Multiple sclerosis (MS) causes dizziness and vertigo. Reports suggest responsible lesions are often in the intra-pontine 8th nerve fascicle. We sought to determine frequency and clinical features of demyelinating acute vestibular syndrome (AVS). This is a prospective observational study (1999-2011).
[A case of multiple sclerosis with intractable hiccups and sleep apnea syndrome].
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
A 48-year-old female with multiple sclerosis (MS) accompanied by intractable hiccups of over one month' duration and the sleep apnea syndrome was reported. This MS patient had been well controlled until September 16, 1991 when she experienced nausea, vomiting and hiccups. The patient was admitted to
Cyclophosphamide in chronic progressive multiple sclerosis. Maintenance vs nonmaintenance therapy.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Twenty-seven patients with chronic progressive multiple sclerosis were treated with high-dose intravenous cyclophosphamide induction on either an impatient or outpatient basis. Following induction, patients were randomized to alternate-month outpatient "maintenance" or "no maintenance" therapy.
The use of baclofen in treatment of spasticity in multiple sclerosis.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Baclofen was used in a double-blind crossover placebo-controlled trial to treat spasticity in patients with multiple sclerosis (MS). While on Baclofen, patients obtained a significant (p less than 0.001) reduction in spasticity compared to controls. The drug was particularly effective in alleviating
Positional nystagmus of the "central type" as an early sign of multiple sclerosis.
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Three young, female adults complained of dizziness and nausea aggravated on lying in supine position. On examination the prominent clinical feature was positional nystagmus of the "central type". All patients finally proved to suffer from multiple sclerosis. Positional nystagmus of the "central
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
